THE PROTECTIVE ROLE OF HUMORAL NEUTRALIZING ANTIBODY IN THE NIH POTENCY TEST FOR RABIES VACCINES

被引：36
|
作者：
WUNDERLI, PS [1 ]
SHADDOCK, JH [1 ]
SCHMID, DS [1 ]
MILLER, TJ [1 ]
BAER, GM [1 ]
机构：
[1] SMITHKLINE BEECHAM ANIM HLTH,KING OF PRUSSIA,PA 19406
来源：
VACCINE | 1991年 / 9卷 / 09期
关键词：
RABIES; HUMORAL NEUTRALIZING ANTIBODY; NIH POTENCY TEST; MICE;
D O I：
10.1016/0264-410X(91)90188-C
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Intraperitoneal vaccination of mice with rabies vaccine results in both dosage-dependent rabies virus neutralizing antibody titres and protection from lethal intracerebral (i.c.) challenge with fixed strain CVS rabies virus. Pre-exposure adoptive intravenous transfer of naive or immune cells did not significantly protect naive Balb/c mice from lethal i.c. CVS challenge, but immune serum and anti-rabies glycoprotein monoclonal antibodies (individually and in combination) did confer significant protection when administered before or up to 24 h after lethal i.c. rabies virus challenge.
引用
收藏
页码：638 / 642
页数：5
相关论文
共 50 条
  • [31] THE ROLE OF THE PRIMARY NEUTRALIZING DETERMINANT (PND) IN PROTECTIVE IMMUNITY ELICITED BY HIV VACCINES IN CHIMPANZEES
    EICHBERG, JW
    PRINCE, AM
    EMINI, EA
    BERMAN, PW
    MATTHEW, T
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (03): : 330 - 330
  • [32] A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody
    Gairola, Sunil
    Gautam, Manish
    Waghmare, Satish
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (08) : 1857 - 1865
  • [33] INVITRO RABIES VACCINE POTENCY APPRAISAL BY ELISA - ADVANTAGES OF THE IMMUNOCAPTURE METHOD WITH A NEUTRALIZING ANTI-GLYCOPROTEIN MONOCLONAL-ANTIBODY
    PERRIN, P
    MORGEAUX, S
    SUREAU, P
    BIOLOGICALS, 1990, 18 (04) : 321 - 330
  • [34] Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality
    Maciejewski, Sonia
    Ruckwardt, Tracy J.
    Morabito, Kaitlyn M.
    Foreman, Bryant M.
    Burgomaster, Katherine E.
    Gordon, David N.
    Pelc, Rebecca
    DeMaso, Christina R.
    Ko, Sung-Youl
    Fisher, Brian E.
    Yang, Eun Sung
    Nair, Deepika
    Foulds, Kathryn E.
    Todd, John Paul
    Kong, Wing Pui
    Roy, Vicky
    Aleshnick, Maya
    Speer, Scott D.
    Bourne, Nigel
    Barrett, Alan D.
    Nason, Martha C.
    Roederer, Mario
    Gaudinski, Martin R.
    Chen, Grace L.
    Dowd, Kimberly A.
    Ledgerwood, Julie E.
    Alter, Galit
    Mascola, John R.
    Graham, Barney S.
    Pierson, Theodore C.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (547)
  • [35] An ELISA-based antigenicity test of rabies recombinant glycoprotein cannot predict its protective potency in vivo
    Volokhov, Dmitriy V.
    Fry, Alethea M.
    Furtak, Vyacheslav
    Jones, R. Mark
    Musiychuk, Konstantin
    Norikane, Joey
    Green, Brian J.
    Srinivas, Geetha B.
    Streatfield, Stephen J.
    Yusibov, Vidadi
    MOLECULAR AND CELLULAR PROBES, 2022, 63
  • [36] Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen
    Verma, Anita
    Ngundi, Miriam M.
    Price, Gregory A.
    Takeda, Kazuyo
    Yu, James
    Burns, Drusilla L.
    MBIO, 2018, 9 (01):
  • [37] Chicken embryo related (CER) cell line for quantification of rabies neutralizing antibody by fluorescent focus inhibition test
    Cardoso, TC
    da Silva, LHQ
    da Silva, SEL
    Albas, A
    Pardo, PE
    Tanaka, AH
    Cossy, LB
    Perri, SHV
    BIOLOGICALS, 2006, 34 (01) : 29 - 32
  • [38] Development of a Time and Cost Benefit Antibody Binding Test-Based Method for Determination of Rabies Vaccine Potency
    Asgary, Vahid
    Mojtabavi, Nazanin
    Janani, Alireza
    Mousavi, Tahereh
    Hadjati, Jamshid
    Khosravy, Mohammad Sadeq
    Cohan, Reza Ahangari
    VIRAL IMMUNOLOGY, 2017, 30 (03) : 204 - 209
  • [39] Suitability of a Vero cell assay as a potency test to assess the neutralizing anti-diphtheria antibody response.
    Arunachalam, AB
    Brinley, RP
    Bybel, MJ
    Hyde, A
    Foose, AR
    Nabors, GS
    FASEB JOURNAL, 2000, 14 (06): : A1238 - A1238
  • [40] Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency
    Turki, Imene
    Hammami, Akil
    Kharmachi, Habib
    Mousli, Mohamed
    MOLECULAR IMMUNOLOGY, 2014, 57 (02) : 66 - 73
12345